Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries

Acta Oncol. 2006;45(4):438-48. doi: 10.1080/02841860600658633.

Abstract

The aim of the study was to assess the risk with radiation therapy and chemotherapy of the first cancer in childhood and adolescence for the development of a second malignant solid tumor (SMST). Also, the role of relapse of the primary tumor was studied. It is a nested case-control study within a Nordic cohort of patients less than 20 years of age at first diagnosis 1960-1987. SMSTs were diagnosed in 1960-1991. There were 196 cases and 567 controls. The risk was increased only for radiotherapy given more than five years before the development of the SMST. A significantly increased relative risk of 1.8 was found already at doses below 1 Gy. The risk increased rapidly up to a maximum of 18.3 for doses above 30 Gy. Chemotherapy alone did not increase the risk to develop an SMST. However, in combination with radiotherapy, chemotherapy showed a significant potentiating effect. Relapse was found to be an independent risk factor for development of an SMST, with a higher relative risk for females than for males.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasms / drug therapy
  • Neoplasms / epidemiology
  • Neoplasms / radiotherapy*
  • Neoplasms, Second Primary / diagnosis*
  • Neoplasms, Second Primary / epidemiology
  • Radiotherapy Dosage*
  • Registries
  • Risk Factors
  • Scandinavian and Nordic Countries / epidemiology

Substances

  • Antineoplastic Agents